Supporting our data, IL-6 is involved in the differentiation and expansion of MDSCs, which can inhibit T-cell via multiple molecular mechanisms (64), and 1MT effectively reverses the recruitment of tumor-infiltrating MDSCs induced by IDO1 (65). This evidence concerns the gene IL6 and neoplasm.